Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response

Publisher： Karger

E-ISSN： 1421-9832|223|1|57-67

ISSN： 1018-8665

Source： Dermatology, Vol.223, Iss.1, 2011-08, pp. : 57-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Skin-Homing Th2/Th22 Cells in Papuloerythroderma of Ofuji

By  

Dermatology, Vol. 228, Iss. 4, 2014-04 ,pp. : 326-331

Karger

Access to resources Recommend Favorite

Efficacy of Etanercept in Psoriatic Patients Previously Treated with Infliximab

By  

Dermatology, Vol. 216, Iss. 4, 2008-01 ,pp. : 312-316

Karger

Access to resources Recommend Favorite

Serum Levels of the Th1 Promoter IL-12 and the Th2 Chemokine TARC Are Elevated in Erythema Multiforme and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Correlate with Soluble Fas Ligand Expression

By  

Dermatology, Vol. 214, Iss. 4, 2007-04 ,pp. : 296-304

Karger

Access to resources Recommend Favorite

Pyoderma Vegetans Associated with Severe Psoriatic Arthritis: Good Response to Etanercept

By  

Dermatology, Vol. 214, Iss. 1, 2006-12 ,pp. : 77-81

Karger

Access to resources Recommend Favorite

Bazex Syndrome in Lung Squamous Cell Carcinoma: High Expression of Epidermal Growth Factor Receptor in Lesional Keratinocytes with Th2 Immune Shift

By  

Case Reports in Dermatology, Vol. 8, Iss. 3, 2016-12 ,pp. : 358-362

Karger

Access to resources Recommend Favorite